Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Michael

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Association of high-dose cyclophosphamide, cisplatin, and carmustine pharmacokinetics with survival, toxicity, and dosing weight in patients with primary breast cancerWilliam P Petros, Gloria Broadwater, Donald Berry, et al.
Journal of the American College of Surgeons|August 25, 2004
In-transit melanoma: the role of alkylating-agent resistance in regional therapyElizabeth G Grubbs, Omar Abdel-Wahab, Tsung-Yen Cheng, et al.
Blood|March 26, 2005
Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34Robert W Storms, Patrick D Green, Kristine M Safford, et al.
Chemical Research in Toxicology|September 21, 2004
1,3- vs 1,5-intramolecular alkylation reactions in isophosphoramide and phosphoramide mustardsJames B Springer, Young H Chang, Kyo I Koo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2005
Associations between drug metabolism genotype, chemotherapy pharmacokinetics, and overall survival in patients with breast cancerWilliam P Petros, Penelope J Hopkins, Susan Spruill, et al.
Journal of Pain and Symptom Management|October 27, 2004
Prostate cancer in African Americans: relationship of patient and partner self-efficacy to quality of lifeLisa C Campbell, Francis J Keefe, Daphne C McKee, et al.
Cancer Chemotherapy and Pharmacology|June 5, 2003
The activity of camptothecin analogues is enhanced in histocultures of human tumors and human tumor xenografts by modulation of extracellular pHJames L Flowers, Robert M Hoffman, Timothy A Driscoll, et al.
Molecular Cancer Therapeutics|August 3, 2007
Pharmacodynamic and pharmacokinetic study of chronic low-dose metronomic cyclophosphamide therapy in miceUrban Emmenegger, Yuval Shaked, Shan Man, et al.
Cancer|December 19, 2006
Facilitating research participation and improving quality of life for African American prostate cancer survivors and their intimate partners. A pilot study of telephone-based coping skills trainingLisa C Campbell, Francis J Keefe, Cindy Scipio, et al.
Molecular Cancer Therapeutics|September 16, 2004
Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutationsManny D Bacolod, Stewart P Johnson, Anthony E Pegg, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Association of high-dose cyclophosphamide, cisplatin, and carmustine pharmacokinetics with survival, toxicity, and dosing weight in patients with primary breast cancerWilliam P Petros, Gloria Broadwater, Donald Berry, et al.
Journal of the American College of Surgeons|August 25, 2004
In-transit melanoma: the role of alkylating-agent resistance in regional therapyElizabeth G Grubbs, Omar Abdel-Wahab, Tsung-Yen Cheng, et al.
Blood|March 26, 2005
Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34Robert W Storms, Patrick D Green, Kristine M Safford, et al.
Chemical Research in Toxicology|September 21, 2004
1,3- vs 1,5-intramolecular alkylation reactions in isophosphoramide and phosphoramide mustardsJames B Springer, Young H Chang, Kyo I Koo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2005
Associations between drug metabolism genotype, chemotherapy pharmacokinetics, and overall survival in patients with breast cancerWilliam P Petros, Penelope J Hopkins, Susan Spruill, et al.
Journal of Pain and Symptom Management|October 27, 2004
Prostate cancer in African Americans: relationship of patient and partner self-efficacy to quality of lifeLisa C Campbell, Francis J Keefe, Daphne C McKee, et al.
Cancer Chemotherapy and Pharmacology|June 5, 2003
The activity of camptothecin analogues is enhanced in histocultures of human tumors and human tumor xenografts by modulation of extracellular pHJames L Flowers, Robert M Hoffman, Timothy A Driscoll, et al.
Molecular Cancer Therapeutics|August 3, 2007
Pharmacodynamic and pharmacokinetic study of chronic low-dose metronomic cyclophosphamide therapy in miceUrban Emmenegger, Yuval Shaked, Shan Man, et al.
Cancer|December 19, 2006
Facilitating research participation and improving quality of life for African American prostate cancer survivors and their intimate partners. A pilot study of telephone-based coping skills trainingLisa C Campbell, Francis J Keefe, Cindy Scipio, et al.
Molecular Cancer Therapeutics|September 16, 2004
Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutationsManny D Bacolod, Stewart P Johnson, Anthony E Pegg, et al.
Pageof 6